Back
Syndax Pharmaceuticals Quote, Financials, Valuation and Earnings
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
15
SNDX
Syndax Pharmaceuticals
Last Price:
15.82
Seasonality Move:
13.57%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereSyndax Pharmaceuticals Price Quote
$15.82
-0.01 (-5.78%)
(Updated: November 16, 2024 at 5:39 AM ET)
Syndax Pharmaceuticals Key Stats
Sell
15
Syndax Pharmaceuticals (SNDX)
is a Sell
Day range:
$15.50 - $16.91
52-week range:
$14.50 - $25.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.91%
Volume:
4.5M
Avg. volume:
1.4M
1-year change:
5.11%
Market cap:
$1.4B
Revenue:
$0
EPS:
$-3.63
How Much Does Syndax Pharmaceuticals Make?
Data Unavailable
Is Syndax Pharmaceuticals Growing As A Company?
Data Unavailable
Syndax Pharmaceuticals Stock Price Performance
-
Did Syndax Pharmaceuticals Stock Go Up Last Month?
Syndax Pharmaceuticals share price went down by -19.85% last month -
Did SNDX's Share Price Rise Over The Last Year?
SNDX share price rose by 5.11% over the past 1 year
What Is Syndax Pharmaceuticals 52-Week High & Low?
-
What Is Syndax Pharmaceuticals’s 52-Week High Share Price?
Syndax Pharmaceuticals has traded as high as $25.34 over the past 52 weeks -
What Is Syndax Pharmaceuticals’s 52-Week Low Share Price?
Syndax Pharmaceuticals has traded as low as $14.50 over the past 52 weeks
Syndax Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Syndax Pharmaceuticals?
-
How Much Debt Does Syndax Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Syndax Pharmaceuticals Have?
Cash and short term investments quarterly total is $406.4M -
What Is Syndax Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.30
Is Syndax Pharmaceuticals Cash Flow Positive?
-
What Is SNDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$258.9M -
What Is Syndax Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $264.4M -
What Is Syndax Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $32.9M
Syndax Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SNDX return on invested capital is -67.33% -
What Is Syndax Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -60.43% -
What Is SNDX Return On Equity?
ROE is a measure of profitability and is -67.33%
Syndax Pharmaceuticals Earnings Date & Stock Price
-
What Is Syndax Pharmaceuticals's Stock Price Today?
A single share of SNDX can be purchased today for 15.83 -
What Is Syndax Pharmaceuticals’s Stock Symbol?
Syndax Pharmaceuticals trades on the nasdaq under the ticker symbol: SNDX -
When Is Syndax Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Syndax Pharmaceuticals is scheduled on February 27, 2025 -
When Is SNDX's next ex-dividend date?
Syndax Pharmaceuticals's next ex-dividend date is November 16, 2024 -
How To Buy Syndax Pharmaceuticals Stock?
You can buy Syndax Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Syndax Pharmaceuticals Competitors
-
Who Are Syndax Pharmaceuticals's Competitors?
Below is a list of companies who compete with Syndax Pharmaceuticals or are related in some way:
Syndax Pharmaceuticals Dividend Yield
-
What Is SNDX Dividend Yield?
Syndax Pharmaceuticals’s dividend yield currently is 0% -
What Is Syndax Pharmaceuticals’s Payout Ratio?
Syndax Pharmaceuticals’s payout ratio is 0% -
When Did Syndax Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is Syndax Pharmaceuticals’s Dividend Per Share?
Syndax Pharmaceuticals pays a dividend of $0.00 per share
Syndax Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 7.57% |
| Revenue: | 0% | 48.83% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 35.14 |
| Upside from Last Price: | 122% |